1-3 of 3
Violet Milliken
Close
Sort by
Journal Articles

Hypogammaglobulinemia Following Rituximab and High-Dose Therapy and Autologous Stem-Cell Transplant: Incidence and Predictors of Prolonged Immunoglobulin Deficiencies

Nancy Pennell, Matthew Cheung, MD SM, FRCP, Lisa K Hicks, MD, MSc, Rena Buckstein, MD, FRCPC, Kevin R Imrie, MD, Eugenia Piliotis, MD, David Spaner, Zeina Ghorab, Marciano D. Reis, MD, Violet Milliken, Angela Boudreau, Neil Berinstein, MD
Journal: Blood
Blood (2008) 112 (11): 4351.
https://doi.org/10.1182/blood.V112.11.4351.4351
Published: 2008
Journal Articles

Prolonged Clinical and Molecular Remissions Following High-Dose Therapy/Autologous Stem Cell Transplantation (HDT/ASCT) and Rituximab and Interferon-alpha Maintenance for Relapsed High-Risk Follicular Lymphoma.

Matthew C. Cheung, MD, Neil L. Berinstein, MD, Nancy Pennell, BSc, Lisa K. Hicks, MD, Kevin R. Imrie, MD, Eugenia Piliotis, MD, Violet Milliken, BSc, Marciano Reis, MD, Rena Buckstein, MD
Journal: Blood
Blood (2007) 110 (11): 1902.
https://doi.org/10.1182/blood.V110.11.1902.1902
Published: 2007
Journal Articles

Rituximab Increases Response to ESHAP in Relapsed, Refractory, and Transformed Aggressive B-Cell Lymphoma.

Lisa Hicks, Rena Buckstein, Joy Mangel, Eugenia Piliotis, Kevin Imrie, Matthew C. Cheung, David E. Spaner, Marciano D. Reis, Zeina Ghorab, Violet Milliken, Nancy Pennell, Neil Berinstein
Journal: Blood
Blood (2006) 108 (11): 3067.
https://doi.org/10.1182/blood.V108.11.3067.3067
Published: 2006